GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Additional Paid-In Capital

Lifecome Biochemistry Co (SZSE:002868) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co Additional Paid-In Capital?


Lifecome Biochemistry Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0.0 Mil) to Dec. 2023 (¥340.5 Mil) but then stayed the same from Dec. 2023 (¥340.5 Mil) to Mar. 2024 (¥0.0 Mil).

Lifecome Biochemistry Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥340.5 Mil) to Dec. 2022 (¥340.5 Mil) and stayed the same from Dec. 2022 (¥340.5 Mil) to Dec. 2023 (¥340.5 Mil).


Lifecome Biochemistry Co Additional Paid-In Capital Historical Data

The historical data trend for Lifecome Biochemistry Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co Additional Paid-In Capital Chart

Lifecome Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 375.89 340.47 340.47 340.47 340.47

Lifecome Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 340.47 - 340.47 -

Lifecome Biochemistry Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Lifecome Biochemistry Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Lifecome Biochemistry Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecome Biochemistry Co (SZSE:002868) Business Description

Traded in Other Exchanges
N/A
Address
No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Executives
Lou Li Jun Supervisors
Huang Hui Executives
Bao Zhong Shou Executives
Feng Zhen Wu Supervisors
Li Jun Hui Executives
Lai Tan Ping Directors, executives
Xu Chun Lin Director
Lai Jian Ping Directors, executives

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines